261 related articles for article (PubMed ID: 18536617)
1. Ovarian status in healthy postmenopausal women.
Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
[TBL] [Abstract][Full Text] [Related]
2. Ovarian status in healthy postmenopausal women: follow-up 12 months after transvaginal ultrasound.
Bell RJ; Healy DL; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
Menopause; 2009; 16(6):1149-55. PubMed ID: 19574938
[TBL] [Abstract][Full Text] [Related]
3. Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
Holbert TR
Am J Obstet Gynecol; 1994 Jun; 170(6):1699-703; discussion 1703-4. PubMed ID: 8203429
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
[TBL] [Abstract][Full Text] [Related]
5. Screening the postmenopausal ovary.
Nachtigall LE
Menopause; 2009; 16(6):1092. PubMed ID: 19779315
[No Abstract] [Full Text] [Related]
6. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
BJOG; 2014 Dec; 121 Suppl 7():35-9. PubMed ID: 25488086
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Sharma A; Burnell M; Gentry-Maharaj A; Campbell S; Amso NN; Seif MW; Fletcher G; Brunel C; Turner G; Rangar R; Ryan A; Jacobs I; Menon U;
Ultrasound Obstet Gynecol; 2013 Oct; 42(4):472-7. PubMed ID: 23456790
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
[TBL] [Abstract][Full Text] [Related]
9. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer screening.
van Nagell JR; Pavlik EJ
Clin Obstet Gynecol; 2012 Mar; 55(1):43-51. PubMed ID: 22343228
[TBL] [Abstract][Full Text] [Related]
11. Total inhibin is a potential serum marker for epithelial ovarian cancer.
Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
[TBL] [Abstract][Full Text] [Related]
12. Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging.
Weiner Z; Beck D; Shteiner M; Borovik R; Ben-Shachar M; Robinzon E; Brandes JM
J Ultrasound Med; 1993 Jul; 12(7):387-93. PubMed ID: 8355333
[TBL] [Abstract][Full Text] [Related]
13. Transvaginal gray-scale and Doppler ultrasound examinations of the uterus and ovaries in healthy postmenopausal women.
Sladkevicius P; Valentin L; Marsàl K
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):81-90. PubMed ID: 8535922
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound.
Modugno F; Weissfeld JL; Hill LM
Gynecol Oncol; 2000 May; 77(2):289-92. PubMed ID: 10785480
[TBL] [Abstract][Full Text] [Related]
15. Changes in ultrasound morphology of the uterus and ovaries during the menopausal transition and early postmenopause: a 4-year longitudinal study.
Sokalska A; Valentin L
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):210-7. PubMed ID: 18197593
[TBL] [Abstract][Full Text] [Related]
16. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
[TBL] [Abstract][Full Text] [Related]
17. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.
Menon U; Talaat A; Jeyarajah AR; Rosenthal AN; MacDonald ND; Skates SJ; Sibley K; Oram DH; Jacobs IJ
Br J Cancer; 1999 Jul; 80(10):1644-7. PubMed ID: 10408412
[TBL] [Abstract][Full Text] [Related]
19. Volumes of normal ovaries, ovaries with benign lesions, and ovaries with cancer in menopausal women: is there an optimal cut-off value to predict malignancy?
Aviram R; Gassner G; Markovitch O; Cohen I; Fishman A; Tepper R
J Clin Ultrasound; 2008 Jan; 36(1):1-5. PubMed ID: 17924576
[TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of transvaginal sonography for detection of ovarian disease.
DiSantis DJ; Scatarige JC; Kemp G; Given FT; Hsiu JG; Cramer MS
AJR Am J Roentgenol; 1993 Jul; 161(1):91-4. PubMed ID: 8517330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
